Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
The addition of the Halcyon system represents a significant milestone in the hospital’s oncology services
Rahul brings over 17 years of experience in human resources leadership across the healthcare, banking, information technology, and FMCG sectors
Healthcare industry leader returns to India to support Apollo Hospitals’ global expansion and advance the ‘Heal in India, Heal by India’ vision
Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments
Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial
Industry body aims to strengthen policy advocacy, innovation, and global competitiveness of India's fast-growing CRDMO sector
Veteran healthcare leader to oversee operations across Tamil Nadu and Kerala, driving growth and operational excellence
Dr. Jain brings extensive experience in the biotech and pharma sectors and has been instrumental in driving innovation, vaccine development, and healthcare advancement
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
